SlideShare une entreprise Scribd logo
1  sur  15
Télécharger pour lire hors ligne
BETTER
TOGETHER
Why pharma companies and
patient organizations need to
collaborate differently to deliver
better patient experiences.
A survey of 4,000 patients in
France, Germany, the UK and
the US.
Patient Inspired. Outcomes Driven.
Copyright © 2019 Accenture. All rights reserved.
2
ABOUTTHE
RESEARCH
Online survey of 4,000 patients across 4
countries and 3 disease states to understand
how patients use and value services from patient
organizations compared to those of pharma
companies and whether integration of those
services would improve the patient experience.
THREEDISEASESTATES
Rheumatoid
Arthritis
Migraine Leukemia N=1000 N=1000 N=1000 N=1000
Copyright © 2019 Accenture. All rights reserved.
3
Who patients prefer to use services from
among pharma companies, healthcare
professionals, pharmacies, payers and
patient organizations for six key areas.
The degree to which patients use
and value services from patient
organization, and why they use
services from patient organizations.
Their level of engagement with patient
organizations now and in the future in
comparison to other healthcare players.
Which patient organizations
are most prominent and why.
If and how the patient experience could
improve with better coordination between
pharma and patient organizations.
WHATWESOUGHTTOUNDERSTAND
PREFERENCE
PROMINENCE
VALUE
ENGAGEMENT
IMPROVEMENT
Copyright © 2019 Accenture. All rights reserved.
4
• They engage early (pre-treatment)
and often with patient organizations
and intend to increase their
engagement with them over the
next two years—more so than they
intend to do so with pharma.
• The vast majority of patients believe
that pharma companies should be
working with patient organizations
to create a more seamless patient
experience.
• Patients highly value services
from patient organizations – and
use them as the primary go-to
provider for emotional support
and patient communities/support.
• Across the board, they prefer to
use services from patient
organizations over those from
pharmaceutical companies.
WHATDOPATIENTSTHINK
about services from patient organizations?
Copyright © 2019 Accenture. All rights reserved.
Patients prefer to use
services from patient
organizations.
Patients rank pharma the
lowest in understanding
them amongst healthcare
players.
Patient organizations
are winning in patient
engagement.
For all six services
questioned, including:
information on therapies
and clinical trials, managing
their condition, emotional
support, community and
patient support groups,
technology to support
them, and financial support.
47% of patients said pharma
companies understood their
emotional, financial and other
needs related to their
condition.
52% of patients are
already engaging more
with patient organizations
on a monthly basis
compared to pharma
companies (35%).
54% of patients said
they are going to engage
with patient organizations
more in the future vs. 35%
with pharma companies.
58% felt that patient
organizations understood
their needs.Over half of patients have
greater trust in and better
experiences with patient
organizations, finding it
easy to engage with them.
KEYFINDINGSSUMMARY
5Copyright © 2019 Accenture. All rights reserved.
6
In terms of helping you manage and recover from your condition, whose services would you prefer to use for each overall area?
Patients prefer to use services from patient
organizations over pharma companies.
Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000)
across all six of the service areas questioned with pharma ranking the lowest in
most services amongst healthcare players including health insurers,
pharmacies and doctor/physicians.
KEY FINDING #1
Copyright © 2019 Accenture. All rights reserved.
7
How willing would you be to share detailed information about the daily impact of your condition with each of the following
organizations, if it helped you receive better care?
Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000)
Patients are willing to share their
data to get better care.
Patients are more willing to share detailed information about the daily impact of their
condition with patient organizations (56%) than they are pharma (49%).
KEY FINDING #1
Copyright © 2019 Accenture. All rights reserved.
8
Which of the following are the top reasons that influenced you the most in choosing to liaise and communicate with this
particular patient organization?
Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000)
Why do patients like engaging
with patient organizations?
Most patients have greater trust in and better experiences with
patient organizations, finding it easy to engage with them.
KEY FINDING #1
Copyright © 2019 Accenture. All rights reserved.
9
How well do you believe each of the following organizations understand your emotional, financial, and other needs
related to daily activities affected by your health condition?
Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000)
Patients say that pharma doesn’t
understand their needs.
Less than half of patients (47%) said pharma companies understood their emotional,
financial and other needs related to their condition—again coming in last compared to
the other players.
KEY FINDING #2
Copyright © 2019 Accenture. All rights reserved.
10
What is the emotional and financial
impact of your condition per day?
Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000)
Don’t underestimate the emotional impact.
Over half (54%) of patients said they feel an emotional impact as a result of
their condition every day. This rose to 72% in the US. Are pharma companies
accounting for this intensive emotional impact on a daily basis in the services
they offer to patients?
KEY FINDING #2
Copyright © 2019 Accenture. All rights reserved.
11
How often do you communicate with each of the following organizations to manage your condition at the level that you desire?
Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000)
s
Patients are already engaging more with patient
organizations on a regular basis (52%).
Compared to pharma companies (35%).
KEY FINDING #3
Copyright © 2019 Accenture. All rights reserved.
12
How do you think your engagement
with the following organizations will
change over the next 2 years?
Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000)
54% of patients said they are going to engage
with patient organizations more in the future.
Compared to 35% for pharma companies.
KEY FINDING #3
Copyright © 2019 Accenture. All rights reserved.
13
How do you engage with the services offered by a patient organization?
Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000)
The new facetime.
While patients are engaging the most with patient organizations by digital means
(online + email), over half of patients are attending events hosted by patient
organizations and calling to talk to a representative over 70% of the time.
KEY FINDING #3
Copyright © 2019 Accenture. All rights reserved.
14
Gain a better understanding
of patient needs—earlier
and more often.
of patients said pharma
companies would better
understand my needs…
By collaborating with patient organizations, pharma can:
of all patients use
services from patient
organizations before
treatment begins.
Provide a more seamless
patient experience.
of patients believe
pharma companies
should be working with
patient organizations…
of patients said pharma
companies would better
understand my needs.
Find new value
for patients.
How can partnering with
patient organization
create the potential to
build entirely new patient
experiences?
<1/3
50%
84%
61%
SOWHATDOESTHISMEAN
FORPHARMA?
Copyright © 2019 Accenture. All rights reserved.
15
CONTACT USKeena Patel
Accenture Life Sciences,
Managing Director,
Intelligent Patient Services
keena.b.patel@accenture.com
Eva Wiedenhöeft
Accenture Life Sciences,
Managing Director, European
Lead—Intelligent Patient Services
eva.wiedenhoeft@accenture.com
linkedin.com/company/
accenture_life_sciences
@AccentureLifeSci
www.accenture.com
/lifesciencesblog
FOR MORE INFORMATION,
PLEASE VISIT:
www.accenture.com/patientservicessurvey
Copyright © 2019 Accenture. All rights reserved.
Accenture and its logo are trademarks of Accenture.

Contenu connexe

Tendances

Tendances (20)

Value Untangled Slideshare
Value Untangled SlideshareValue Untangled Slideshare
Value Untangled Slideshare
 
Human Services as a Platform: Three Keys to Success in Platform Driven Digita...
Human Services as a Platform: Three Keys to Success in Platform Driven Digita...Human Services as a Platform: Three Keys to Success in Platform Driven Digita...
Human Services as a Platform: Three Keys to Success in Platform Driven Digita...
 
Perspectives on the Future of Remote Work for States
Perspectives on the Future of Remote Work for StatesPerspectives on the Future of Remote Work for States
Perspectives on the Future of Remote Work for States
 
Clinical Services and Technology
Clinical Services and TechnologyClinical Services and Technology
Clinical Services and Technology
 
2016 Edelman TRUST BAROMETER - Global Results
2016 Edelman TRUST BAROMETER - Global Results2016 Edelman TRUST BAROMETER - Global Results
2016 Edelman TRUST BAROMETER - Global Results
 
Research and Development Solutions | Accenture
Research and Development Solutions | AccentureResearch and Development Solutions | Accenture
Research and Development Solutions | Accenture
 
Driving Digitalization in Biopharma R&D
Driving Digitalization in Biopharma R&DDriving Digitalization in Biopharma R&D
Driving Digitalization in Biopharma R&D
 
INTIENT Patient
INTIENT Patient INTIENT Patient
INTIENT Patient
 
Introduction to Digital Health (EN)
Introduction to Digital Health (EN)Introduction to Digital Health (EN)
Introduction to Digital Health (EN)
 
Accenture Tech Vision 2020 - Trend 5
Accenture Tech Vision 2020 - Trend 5Accenture Tech Vision 2020 - Trend 5
Accenture Tech Vision 2020 - Trend 5
 
Digital Healthcare Trends: Transformation Towards Better Care Relationship
Digital Healthcare Trends: Transformation Towards Better Care RelationshipDigital Healthcare Trends: Transformation Towards Better Care Relationship
Digital Healthcare Trends: Transformation Towards Better Care Relationship
 
Health Experience: The difference between loyalty & leaving
Health Experience: The difference between loyalty & leavingHealth Experience: The difference between loyalty & leaving
Health Experience: The difference between loyalty & leaving
 
Novartis.trends.3.6.15
Novartis.trends.3.6.15Novartis.trends.3.6.15
Novartis.trends.3.6.15
 
Creating Revenue from Customer Data
Creating Revenue from Customer DataCreating Revenue from Customer Data
Creating Revenue from Customer Data
 
Digital Marketing for Pharma
Digital Marketing for PharmaDigital Marketing for Pharma
Digital Marketing for Pharma
 
Engineering Services: con gli ingegneri per creare valore sostenibile
Engineering Services: con gli ingegneri per creare valore sostenibileEngineering Services: con gli ingegneri per creare valore sostenibile
Engineering Services: con gli ingegneri per creare valore sostenibile
 
Finding Your First Customers
Finding Your First CustomersFinding Your First Customers
Finding Your First Customers
 
IDN 101
IDN 101IDN 101
IDN 101
 
Case study of 1mg
Case study of 1mgCase study of 1mg
Case study of 1mg
 
2014 Edelman Trust Barometer - Global Results
2014 Edelman Trust Barometer - Global Results2014 Edelman Trust Barometer - Global Results
2014 Edelman Trust Barometer - Global Results
 

Similaire à Better Together: 2019 Patient Services Survey

Millennial Mindset - Collaborative Clinician [lo res spreads]
Millennial Mindset - Collaborative Clinician [lo res spreads]Millennial Mindset - Collaborative Clinician [lo res spreads]
Millennial Mindset - Collaborative Clinician [lo res spreads]
Amanda Cote Loban
 

Similaire à Better Together: 2019 Patient Services Survey (20)

Better Together: 2019 Patient Services Survey - Country Results
Better Together: 2019 Patient Services Survey - Country ResultsBetter Together: 2019 Patient Services Survey - Country Results
Better Together: 2019 Patient Services Survey - Country Results
 
Better Together 2019 Patient Services Survey - Condition Results
Better Together 2019 Patient Services Survey - Condition ResultsBetter Together 2019 Patient Services Survey - Condition Results
Better Together 2019 Patient Services Survey - Condition Results
 
Better Together 2019 Patient Services Survey - Condition Results
Better Together 2019 Patient Services Survey - Condition ResultsBetter Together 2019 Patient Services Survey - Condition Results
Better Together 2019 Patient Services Survey - Condition Results
 
2016 Healthcare Trends
2016 Healthcare Trends2016 Healthcare Trends
2016 Healthcare Trends
 
Summary of Top Ten Health Industry Issues
Summary of Top Ten Health Industry IssuesSummary of Top Ten Health Industry Issues
Summary of Top Ten Health Industry Issues
 
Pharma Industry Trends in 2015
Pharma Industry Trends in 2015Pharma Industry Trends in 2015
Pharma Industry Trends in 2015
 
mHealth Israel_GEARING COMMUNICATIONS TO RAISE CAPITAL AND ATTRACT CUSTOMERS_...
mHealth Israel_GEARING COMMUNICATIONS TO RAISE CAPITAL AND ATTRACT CUSTOMERS_...mHealth Israel_GEARING COMMUNICATIONS TO RAISE CAPITAL AND ATTRACT CUSTOMERS_...
mHealth Israel_GEARING COMMUNICATIONS TO RAISE CAPITAL AND ATTRACT CUSTOMERS_...
 
Marketing in the Age of Person-centric Healthcare
Marketing in the Age of Person-centric HealthcareMarketing in the Age of Person-centric Healthcare
Marketing in the Age of Person-centric Healthcare
 
Social media and pharma
Social media and pharmaSocial media and pharma
Social media and pharma
 
Millennial Mindset - Collaborative Clinician [lo res spreads]
Millennial Mindset - Collaborative Clinician [lo res spreads]Millennial Mindset - Collaborative Clinician [lo res spreads]
Millennial Mindset - Collaborative Clinician [lo res spreads]
 
Healthcare's Digital Future
Healthcare's Digital Future Healthcare's Digital Future
Healthcare's Digital Future
 
From Patients to ePatients Driving a new paradigm for online clinical collabo...
From Patients to ePatients Driving a new paradigm for online clinical collabo...From Patients to ePatients Driving a new paradigm for online clinical collabo...
From Patients to ePatients Driving a new paradigm for online clinical collabo...
 
Annual healthcare-professional-communication-report-2016
Annual healthcare-professional-communication-report-2016Annual healthcare-professional-communication-report-2016
Annual healthcare-professional-communication-report-2016
 
Patients Like Me
Patients Like MePatients Like Me
Patients Like Me
 
10 healthcare marketing statistics that matter now
10 healthcare marketing statistics that matter now10 healthcare marketing statistics that matter now
10 healthcare marketing statistics that matter now
 
Digital health in Asia
Digital health in AsiaDigital health in Asia
Digital health in Asia
 
Where does pharma marketing go from here
Where does pharma marketing go from hereWhere does pharma marketing go from here
Where does pharma marketing go from here
 
Digital Pharmaeng Effective Web Marketingnovember 07 1230298508923930 2
Digital Pharmaeng Effective Web Marketingnovember 07 1230298508923930 2Digital Pharmaeng Effective Web Marketingnovember 07 1230298508923930 2
Digital Pharmaeng Effective Web Marketingnovember 07 1230298508923930 2
 
Digital Pharma: Evolution and Revolution in Marketing & Sales
Digital Pharma: Evolution and Revolution in Marketing & SalesDigital Pharma: Evolution and Revolution in Marketing & Sales
Digital Pharma: Evolution and Revolution in Marketing & Sales
 
130609
130609130609
130609
 

Plus de accenture

Plus de accenture (20)

The Industrialist: Trends & Innovations - January 2024
The Industrialist: Trends & Innovations - January 2024The Industrialist: Trends & Innovations - January 2024
The Industrialist: Trends & Innovations - January 2024
 
The Industrialist: Trends & Innovations - September 2023
The Industrialist: Trends & Innovations - September 2023The Industrialist: Trends & Innovations - September 2023
The Industrialist: Trends & Innovations - September 2023
 
Accenture Technology Vision - How the trends apply to higher education
Accenture Technology Vision - How the trends apply to higher education Accenture Technology Vision - How the trends apply to higher education
Accenture Technology Vision - How the trends apply to higher education
 
The Industrialist: Trends & Innovations - July 2023
The Industrialist: Trends & Innovations - July 2023The Industrialist: Trends & Innovations - July 2023
The Industrialist: Trends & Innovations - July 2023
 
Accenture Technology Vision - How the trends apply to higher education
Accenture Technology Vision - How the trends apply to higher education Accenture Technology Vision - How the trends apply to higher education
Accenture Technology Vision - How the trends apply to higher education
 
Digital Euro: Implications for the Financial System
Digital Euro: Implications for the Financial SystemDigital Euro: Implications for the Financial System
Digital Euro: Implications for the Financial System
 
More deals, less money: the Black founder funding journey
More deals, less money: the Black founder funding journeyMore deals, less money: the Black founder funding journey
More deals, less money: the Black founder funding journey
 
The Industrialist: Trends & Innovations - June 2023
The Industrialist: Trends & Innovations - June 2023The Industrialist: Trends & Innovations - June 2023
The Industrialist: Trends & Innovations - June 2023
 
Reinventing Enterprise Operations
Reinventing Enterprise OperationsReinventing Enterprise Operations
Reinventing Enterprise Operations
 
Semiconductor Gender Parity Study
Semiconductor Gender Parity StudySemiconductor Gender Parity Study
Semiconductor Gender Parity Study
 
The Industrialist: Trends & Innovations - March 2023
The Industrialist: Trends & Innovations - March 2023The Industrialist: Trends & Innovations - March 2023
The Industrialist: Trends & Innovations - March 2023
 
Nonprofit reinvention in a time of unprecedented change
 Nonprofit reinvention in a time of unprecedented change Nonprofit reinvention in a time of unprecedented change
Nonprofit reinvention in a time of unprecedented change
 
Free to be 100% me
Free to be 100% meFree to be 100% me
Free to be 100% me
 
The Industrialist: Trends & Innovations - February 2023
The Industrialist: Trends & Innovations - February 2023The Industrialist: Trends & Innovations - February 2023
The Industrialist: Trends & Innovations - February 2023
 
Mundo gamer e a oportunidade de entrada pela abordagem do movimento
Mundo gamer e a oportunidade de entrada pela abordagem do movimentoMundo gamer e a oportunidade de entrada pela abordagem do movimento
Mundo gamer e a oportunidade de entrada pela abordagem do movimento
 
Pathways to Profitability for the Communications Industry
Pathways to Profitability for the Communications IndustryPathways to Profitability for the Communications Industry
Pathways to Profitability for the Communications Industry
 
The Industrialist: Trends & Innovations - January 2023
The Industrialist: Trends & Innovations - January 2023The Industrialist: Trends & Innovations - January 2023
The Industrialist: Trends & Innovations - January 2023
 
Reimagining the Agenda | Accenture
Reimagining the Agenda | AccentureReimagining the Agenda | Accenture
Reimagining the Agenda | Accenture
 
Climate Leadership Eleventh Hour | Accenture
Climate Leadership Eleventh Hour | AccentureClimate Leadership Eleventh Hour | Accenture
Climate Leadership Eleventh Hour | Accenture
 
Sustainable Value Chain
Sustainable Value ChainSustainable Value Chain
Sustainable Value Chain
 

Dernier

Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Victor Rentea
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Safe Software
 

Dernier (20)

Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
 
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ..."I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
 
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
 
Vector Search -An Introduction in Oracle Database 23ai.pptx
Vector Search -An Introduction in Oracle Database 23ai.pptxVector Search -An Introduction in Oracle Database 23ai.pptx
Vector Search -An Introduction in Oracle Database 23ai.pptx
 
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, AdobeApidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
 
CNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In PakistanCNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In Pakistan
 
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
 
presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century education
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
 
Understanding the FAA Part 107 License ..
Understanding the FAA Part 107 License ..Understanding the FAA Part 107 License ..
Understanding the FAA Part 107 License ..
 
MS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectorsMS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectors
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
Elevate Developer Efficiency & build GenAI Application with Amazon Q​
Elevate Developer Efficiency & build GenAI Application with Amazon Q​Elevate Developer Efficiency & build GenAI Application with Amazon Q​
Elevate Developer Efficiency & build GenAI Application with Amazon Q​
 
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot ModelMcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot Model
 
Platformless Horizons for Digital Adaptability
Platformless Horizons for Digital AdaptabilityPlatformless Horizons for Digital Adaptability
Platformless Horizons for Digital Adaptability
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
 
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
 

Better Together: 2019 Patient Services Survey

  • 1. BETTER TOGETHER Why pharma companies and patient organizations need to collaborate differently to deliver better patient experiences. A survey of 4,000 patients in France, Germany, the UK and the US. Patient Inspired. Outcomes Driven. Copyright © 2019 Accenture. All rights reserved.
  • 2. 2 ABOUTTHE RESEARCH Online survey of 4,000 patients across 4 countries and 3 disease states to understand how patients use and value services from patient organizations compared to those of pharma companies and whether integration of those services would improve the patient experience. THREEDISEASESTATES Rheumatoid Arthritis Migraine Leukemia N=1000 N=1000 N=1000 N=1000 Copyright © 2019 Accenture. All rights reserved.
  • 3. 3 Who patients prefer to use services from among pharma companies, healthcare professionals, pharmacies, payers and patient organizations for six key areas. The degree to which patients use and value services from patient organization, and why they use services from patient organizations. Their level of engagement with patient organizations now and in the future in comparison to other healthcare players. Which patient organizations are most prominent and why. If and how the patient experience could improve with better coordination between pharma and patient organizations. WHATWESOUGHTTOUNDERSTAND PREFERENCE PROMINENCE VALUE ENGAGEMENT IMPROVEMENT Copyright © 2019 Accenture. All rights reserved.
  • 4. 4 • They engage early (pre-treatment) and often with patient organizations and intend to increase their engagement with them over the next two years—more so than they intend to do so with pharma. • The vast majority of patients believe that pharma companies should be working with patient organizations to create a more seamless patient experience. • Patients highly value services from patient organizations – and use them as the primary go-to provider for emotional support and patient communities/support. • Across the board, they prefer to use services from patient organizations over those from pharmaceutical companies. WHATDOPATIENTSTHINK about services from patient organizations? Copyright © 2019 Accenture. All rights reserved.
  • 5. Patients prefer to use services from patient organizations. Patients rank pharma the lowest in understanding them amongst healthcare players. Patient organizations are winning in patient engagement. For all six services questioned, including: information on therapies and clinical trials, managing their condition, emotional support, community and patient support groups, technology to support them, and financial support. 47% of patients said pharma companies understood their emotional, financial and other needs related to their condition. 52% of patients are already engaging more with patient organizations on a monthly basis compared to pharma companies (35%). 54% of patients said they are going to engage with patient organizations more in the future vs. 35% with pharma companies. 58% felt that patient organizations understood their needs.Over half of patients have greater trust in and better experiences with patient organizations, finding it easy to engage with them. KEYFINDINGSSUMMARY 5Copyright © 2019 Accenture. All rights reserved.
  • 6. 6 In terms of helping you manage and recover from your condition, whose services would you prefer to use for each overall area? Patients prefer to use services from patient organizations over pharma companies. Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000) across all six of the service areas questioned with pharma ranking the lowest in most services amongst healthcare players including health insurers, pharmacies and doctor/physicians. KEY FINDING #1 Copyright © 2019 Accenture. All rights reserved.
  • 7. 7 How willing would you be to share detailed information about the daily impact of your condition with each of the following organizations, if it helped you receive better care? Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000) Patients are willing to share their data to get better care. Patients are more willing to share detailed information about the daily impact of their condition with patient organizations (56%) than they are pharma (49%). KEY FINDING #1 Copyright © 2019 Accenture. All rights reserved.
  • 8. 8 Which of the following are the top reasons that influenced you the most in choosing to liaise and communicate with this particular patient organization? Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000) Why do patients like engaging with patient organizations? Most patients have greater trust in and better experiences with patient organizations, finding it easy to engage with them. KEY FINDING #1 Copyright © 2019 Accenture. All rights reserved.
  • 9. 9 How well do you believe each of the following organizations understand your emotional, financial, and other needs related to daily activities affected by your health condition? Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000) Patients say that pharma doesn’t understand their needs. Less than half of patients (47%) said pharma companies understood their emotional, financial and other needs related to their condition—again coming in last compared to the other players. KEY FINDING #2 Copyright © 2019 Accenture. All rights reserved.
  • 10. 10 What is the emotional and financial impact of your condition per day? Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000) Don’t underestimate the emotional impact. Over half (54%) of patients said they feel an emotional impact as a result of their condition every day. This rose to 72% in the US. Are pharma companies accounting for this intensive emotional impact on a daily basis in the services they offer to patients? KEY FINDING #2 Copyright © 2019 Accenture. All rights reserved.
  • 11. 11 How often do you communicate with each of the following organizations to manage your condition at the level that you desire? Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000) s Patients are already engaging more with patient organizations on a regular basis (52%). Compared to pharma companies (35%). KEY FINDING #3 Copyright © 2019 Accenture. All rights reserved.
  • 12. 12 How do you think your engagement with the following organizations will change over the next 2 years? Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000) 54% of patients said they are going to engage with patient organizations more in the future. Compared to 35% for pharma companies. KEY FINDING #3 Copyright © 2019 Accenture. All rights reserved.
  • 13. 13 How do you engage with the services offered by a patient organization? Base: Total Respondents (4000) USA (1000) UK (1000) France (1000) Germany (1000) The new facetime. While patients are engaging the most with patient organizations by digital means (online + email), over half of patients are attending events hosted by patient organizations and calling to talk to a representative over 70% of the time. KEY FINDING #3 Copyright © 2019 Accenture. All rights reserved.
  • 14. 14 Gain a better understanding of patient needs—earlier and more often. of patients said pharma companies would better understand my needs… By collaborating with patient organizations, pharma can: of all patients use services from patient organizations before treatment begins. Provide a more seamless patient experience. of patients believe pharma companies should be working with patient organizations… of patients said pharma companies would better understand my needs. Find new value for patients. How can partnering with patient organization create the potential to build entirely new patient experiences? <1/3 50% 84% 61% SOWHATDOESTHISMEAN FORPHARMA? Copyright © 2019 Accenture. All rights reserved.
  • 15. 15 CONTACT USKeena Patel Accenture Life Sciences, Managing Director, Intelligent Patient Services keena.b.patel@accenture.com Eva Wiedenhöeft Accenture Life Sciences, Managing Director, European Lead—Intelligent Patient Services eva.wiedenhoeft@accenture.com linkedin.com/company/ accenture_life_sciences @AccentureLifeSci www.accenture.com /lifesciencesblog FOR MORE INFORMATION, PLEASE VISIT: www.accenture.com/patientservicessurvey Copyright © 2019 Accenture. All rights reserved. Accenture and its logo are trademarks of Accenture.